S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|XOMA Initiates U.S. Clinical Trial of Gevokizumab in Patients With Behcet's Disease Uveitis - EYEGUARD(TM)-US|
|XOMA Launches XOMA 358 Clinical Development|
|XOMA Highlights Recent Achievements and Reports Financial Results for the Third Quarter of 2014|
|The Texas A&M University System and XOMA License Innovative Manufacturing Technology|
|XOMA Initiates Pivotal Phase 3 Gevokizumab Study in Patients With Pyoderma Gangrenosum|
|XOMA to Present at Upcoming Investor Conferences|
|XOMA to Present at the Piper Jaffray Healthcare Conference|
|XOMA to Announce Third Quarter 2014 Financial Results and Host Webcast on November 6|
|XOMA Announces Pricing of $40.0 Million Registered Offering of Common Stock and Warrants|
Click above to view more mutual fund data and stats for xoma - XOMA Corp.